Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06214949 · ClinicalTrials.gov registry record · NA

Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS)

A NA study of Neck Pain, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT06214949: Recruiting NA study of Neck Pain, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.

NCT06214949 is a NA study of Neck Pain that is actively recruiting participants, run by Henry M. Jackson Foundation for the Advancement of Military Medicine. The registered enrollment target is 120 participants, below the 1,186-participant average among 31 other Neck Pain trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06214949, a NA study of Neck Pain, is actively recruiting participants, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

This study aims to assess the efficacy of Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS) therapy to reduce chronic neck for military health system beneficiaries.

Primary Outcome

The DVPRS was developed to standardize pain measurement across all health care settings and promote pain assessment and reassessment practices. DVPRS is a visual pain scale to assess individual's pain intensity on a scale of 0-10, with an additional 4 questions to assess pain's interference with the participant's activity, sleep, mood, and stress. The scale has excellent internal reliability and test-retest reliability.

Conditions Studied

Interventions

  • DEVICE Personalized Repetitive Transcranial Magnetic Stimulation
  • DEVICE Sham Personalized Repetitive Transcranial Magnetic Stimulation

Study Locations (1)

Maryland

  • Walter Reed National Military Medical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2024-05-01
Est. Completion 2027-05
Phase NA

What NCT06214949 shows while recruiting

NCT06214949 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,186-participant average among 31 other Neck Pain trials with a reported enrollment target (90% lower).

The record links to 1 condition, with Neck Pain appearing as the primary indexed condition, and to 2 interventions - of which Personalized Repetitive Transcranial Magnetic Stimulation is the first listed.

NCT06214949 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT06214949 about?

NCT06214949 is a clinical study titled "Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS)". This study aims to assess the efficacy of Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS) therapy to reduce chronic neck for military health system beneficiaries.

What is the current status of trial NCT06214949?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2024-05-01. Estimated completion is 2027-05.

What conditions does trial NCT06214949 study?

This clinical trial studies the following conditions: Neck Pain.

What interventions are being tested in trial NCT06214949?

The interventions under investigation include: Personalized Repetitive Transcranial Magnetic Stimulation (DEVICE), Sham Personalized Repetitive Transcranial Magnetic Stimulation (DEVICE).

Who is sponsoring clinical trial NCT06214949?

This trial is sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine, which has 60 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06214949 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Neck Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06214949's enrollment target sits among peer trials

120 13th of 31 higher than 18 of 31 other Neck Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Neck Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06214949, the US trial registry maintained by the National Library of Medicine. NCT06214949 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.